Table 3

Medical treatment for primary breast cancer in the study patients (N = 198)

Therapy type

Intervention

n (%)


Adjuvant hormone therapy

No hormone therapy

137 (69.2)

Tamoxifen

61 (30.8)

Adjuvant chemotherapy

Anthracycline-containing regimens

46 (23.2)

Anthracycline-free regimens

36 (18.2)

No chemotherapy

116 (58.6)

No adjuvant therapy

55 (27.8)


Fritz et al. Breast Cancer Research 2005 7:R374-R384   doi:10.1186/bcr1012

Open Data